1. The Current Landscape of Systemic Therapies for Advanced Hepatocellular Carcinoma

   • Prachi Rana
   • John Haydek
   • Anjana Pillai

   Hepatic Cancer (N Parikh, Section Editor) 28 November 2019 Pages: 371 - 382

2. Harms of Hepatocellular Carcinoma Surveillance

   • Jan Petrasek
   • Amit G. Singal
   • Nicole E. Rich

   Hepatic Cancer (N Parikh, Section Editor) 15 October 2019 Pages: 383 - 389

3. Liquid Biopsy for Hepatocellular Carcinoma

   • Vincent L. Chen
   • Neehar D. Parikh

   Hepatic Cancer (N Parikh, Section Editor) 29 October 2019 Pages: 390 - 399

4. Downstaging and Expanded Criteria Hepatocellular Carcinoma Liver Transplantation

   • Phillipe Abreu
   • Andre Gorgen
   • Gonzalo Sapisochin

   Hepatic Cancer (N Parikh, Section Editor) 22 October 2019 Pages: 400 - 407

5. Screening Indications and Treatments for Cholangiocarcinoma

   • Joseph C. Ahn
   • Ju Dong Yang

   Hepatic Cancer (N Parikh, Section Editor) 31 October 2019 Pages: 408 - 416

   

6. Spectrum of Drug Induced Liver Injury Caused by Anabolic Androgenic Steroids Abuse

   • Varun Takyar
   • Andrew Stolz

   Drug-Induced Liver Injury (P Hayashi, Section Editor) 26 November 2019 Pages: 417 - 424

   

7. NAFLD in Women: Unique Pathways, Biomarkers, and Therapeutic Opportunities

   • Liyun Yuan
   • Ani Kardashian
   • Monika Sarkar

   Fatty Liver Disease (V Ajmera, Section Editor) 18 November 2019 Pages: 425 - 432

   

8. Should We Screen High-Risk Populations for NAFLD?

   • Cyrielle Caussy

   Fatty Liver Disease (V Ajmera, Section Editor) 08 November 2019 Pages: 433 - 443

   

9. Medical Approach for Weight Loss in Nonalcoholic Fatty Liver Disease

   • Albert Do
   • Ysabel C. Ilagan-Ying
   • Wajahat Z. Mehal

   Fatty Liver Disease (V Ajmera, Section Editor) 21 November 2019 Pages: 444 - 454

   

10. Extrahepatic Malignancies in Nonalcoholic Fatty Liver Disease

    • Omar T. Ahmed
    • Alina M. Allen

    Fatty Liver Disease (V Ajmera, Section Editor) 15 November 2019 Pages: 455 - 472

11. NAFLD Histology: a Critical Review and Comparison of Scoring Systems

    • Rish K. Pai

    Fatty Liver Disease (V Ajmera, Section Editor) 04 November 2019 Pages: 473 - 481

    

12. HIV-Associated NAFLD: Disease Burden and Management

    • Alyson Kaplan
    • Jennifer C. Price

    Fatty Liver Disease (V Ajmera, Section Editor) 15 November 2019 Pages: 482 - 491

13. Quantification of Liver Fat in NAFLD: Available Modalities and Clinical Significance

    • Kee-Huat Chuah
    • Wah-Kheong Chan

    Fatty Liver Disease (V Ajmera, Section Editor) 11 November 2019 Pages: 492 - 502

14. Future Therapies for Functional Cure of Chronic HBV: Review of Investigational Drugs in Phase 1 and 2 Development

    • Lung-Yi Mak
    • Wai-Kay Seto
    • Man-Fung Yuen

    Hepatitis B (J Lim, Section Editor) 01 November 2019 Pages: 503 - 511

    

15. Evidence-Based Approach to Stopping Oral Antiviral Therapy in Chronic HBV

    • Maximilian Wübbolding
    • Markus Cornberg
    • Christoph Höner zu Siederdissen

    Hepatitis B (J Lim, Section Editor) 11 November 2019 Pages: 512 - 521

    

16. Update in Drug Development for Chronic HBV/HDV Infection

    • Dulce Alfaiate
    • Francesco Negro

    Hepatitis B (J Lim, Section Editor) 27 November 2019 Pages: 522 - 530

    

17. Correction to: Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma

    • Byung-Han Rhieu
    • Amol K. Narang
    • Jeffrey Meyer

    Correction Open access 16 September 2019 Pages: 531 - 531